Accession Number:

AD1166795

Title:

CD8 T-cell Infiltration as a Predictor of Renal Cancer Progression After Surgery

Descriptive Note:

[Technical Report, Annual Report]

Corporate Author:

EMORY UNIV ATLANTA GA

Personal Author(s):

Report Date:

2021-10-01

Pagination or Media Count:

16

Abstract:

Kidney cancer patients with AJCCTNM Stage III disease represent a significant challenge in selecting the care that should be received after surgery. According to 2019 NCCN guidelines, the decision is whether these patients should either receive sunitinib, enter a clinical trial, or be placed on surveillance. Potentially, this may represent overtreatment or oversurveillance for some patients who are cured, and undertreatment for others. Currently, there are not good indicators to guide which path patients should be follow, thus, appropriate biomarkers are needed to improve prognostication for patients with this stage of disease.

Subject Categories:

  • Medicine and Medical Research
  • Anatomy and Physiology

Distribution Statement:

[A, Approved For Public Release]